Clinical and Translational Oncology
A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims
A prospective biological study in relation to a family with Li-Fraumeni syndrome
Advances in cutaneous melanoma
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Biochemical control of prostate cancer with iodine-125 brachytherapy alone: experience from a single institution
Biomarker testing in non-small cell lung cancer: to move forward with quality
Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed
Episcleral brachytherapy for uveal melanoma: analysis of 136 cases
Evaluation of retroperitoneoscopic partial nephrectomy with in situ hypothermic perfusion
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
Need to implement a coordinated and multidisciplinary care in the Spanish population at increased risk for colorectal cancer
Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma
Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls
Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo